{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:37:41Z","timestamp":1790095061778,"version":"4.0.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"\n Background:<\/jats:bold>\n According to the theory of traditional Chinese medicine, phlegm and blood stasis (PBS) is the pathological basis for coronary heart disease (CHD). This study aimed to explore the biological basis of PBS syndrome in CHD.\n <\/jats:p>\n \n Methods:<\/jats:bold>\n Using a strategy that integrated RNA-seq, DIA-based proteomics, and untargeted metabolomics on 90 clinic samples, we constructed a \u201cgene\u2013protein\u2013metabolite\u201d network for CHD-PBS syndrome. We expanded the sample size and validated the differential genes and metabolites in the network through enzyme-linked immunosorbent assay.\n <\/jats:p>\n \n Results:<\/jats:bold>\n Our findings revealed that the \u201cgene\u2013protein\u2013metabolite\u201d network of CHD-PBS syndrome included 33 mRNAs, four proteins, and 25 metabolites. JNK1, FOS, CCL2, CXCL8, PTGS2, and CSF1 were all poorly expressed in the PBS group during the sequencing stage, whereas arachidonic acid (AA) was highly expressed. During the validation stage, JNK1, AP-1, CCL2, and CXCL8 were poorly expressed, whereas PTGS2, CSF1, and AA were highly expressed. The area under the receiver operating curve was as follows: CSF1 [0.9635, 95%CI (0.9295, 0.9976)] &gt;JNK1 [0.9361, 95% CI (0.8749, 0.9972)] &gt;CXCL8 [0.8953, 95% CI (0.8222, 0.9684)] &gt; CCL2 [0.8458, 95% CI (0.7676, 0.9241)] &gt;AP-1 [0.7884, 95%CI (0.6869, 0.8899)]. The logistic regression model composed of CSF1 and JNK1 showed the greatest diagnostic value and significance for PBS syndrome.\n <\/jats:p>\n \n Conclusion:<\/jats:bold>\n PBS syndrome is characterized by low levels of FOS, AP-1, CCL2, CXCL8, and JNK1 and elevated levels of PTGS2 and CSF1, implying that the AA metabolism is abnormal and that the JNK\/AP-1 pathway is inhibited. PBS syndromes, as a subtype of CHD, may have unique molecular changes. Background. Globally, coronary heart disease (CHD) is the leading cause of death, and this would likely continue until 2030 (\n Mirzaei et al., 2009<\/jats:xref>\n , 95, 740\u2013746). According to the disease course, CHD can be classified as chronic stable CHD (or chronic coronary syndrome) and acute coronary syndrome (ACS) (\n Katus et al., 2017<\/jats:xref>\n ;\n Knuuti, 2019<\/jats:xref>\n ). Although stable CHD is not as lethal as ACS, it has a varied incidence range and patients with CHD have prolonged angina. Some symptoms of stable angina are alleviated with pharmacological therapy, but it cannot eliminate recurrent angina (\n Rousan et al., 2017<\/jats:xref>\n ). The clinical outcomes were not significantly improved in patients who underwent revascularization compared with those who received optimal pharmacological therapy (\n Shaw et al., 2008<\/jats:xref>\n ;\n Antman and Braunwald, 2020<\/jats:xref>\n ). A bottleneck appears to exist in CHD treatment, and traditional Chinese medicine (TCM) can act as a favorable complement. Because of its individualized treatment approach, TCM is widely practiced in eastern civilizations (\n Teng et al., 2016<\/jats:xref>\n ). TCM has become a principal complement in western countries (\n Wieland et al., 2013<\/jats:xref>\n ). Like \u201cdisease\u201d is used in western medicine, \u201csyndrome\u201d is used in TCM to comprehend anomalous human conditions on the basis of patients\u2019 symptoms, tongue, and pulse (\n Li et al., 2012<\/jats:xref>\n ). On the basis of disease-syndrome diagnose, a TCM doctor can subclassify CHD patients into various categories, such as phlegm and blood stasis (PBS) syndrome, cold congealing and Qi stagnation syndrome, and Qi stagnation and blood stasis syndrome. PBS syndrome has recently emerged as a hot research topic in the TCM field. Objective diagnosis, expert consultations, and efficacy evaluation scales have been developed for PBS syndrome (\n Ren et al., 2020<\/jats:xref>\n ;\n Liu et al., 2021<\/jats:xref>\n ;\n Zheng et al., 2022<\/jats:xref>\n ). The concept of \u201comics\u201d originates from the genome. It refers to the vocabulary generated by biological molecules at different levels to describe high-sequence molecular biological data resources (\n Dai and Shen, 2022<\/jats:xref>\n ). RNA, protein, and metabolites decipher the essence of complex etiologies, and the integration of transcriptomics, proteomics, and metabolomics are becoming a promising research mode (\n Pan et al., 2022<\/jats:xref>\n ). Multi-omics studies have revealed the biological characteristics of APOE transgenic mice, bronchopulmonary dysplasia, and plant tolerant to heavy metals (\n Singh et al., 2016<\/jats:xref>\n ;\n Lal et al., 2018<\/jats:xref>\n ;\n Mohler et al., 2020<\/jats:xref>\n ). Over the past few years, many academic achievements related to CHD-PBS syndrome have been accrued in the single-omic area. For example, Zhou identified the differential metabolites between PBS syndrome and Qi and Yin deficiency syndrome by using the urine samples of 1072 volunteers. Some of the specific metabolites of PBS syndrome are pyroglutamic acid, glutaric acid, glucose, mannitol, and xanthine (\n Zhou et al., 2019<\/jats:xref>\n ). Li\u2019s metabolomic study suggested that valine, leucine, isoleucine, and glycerol phospholipid metabolism could represent PBS syndrome (\n Zheng et al., 2022<\/jats:xref>\n ). Although some progress has been made in the understanding of PBS syndrome in CHD through the studies conducted, some issues still exist, such as a single-omics level, a lack of in-depth research, an inability to verify each other\u2019s research results, and a lack of validation of research conclusions. Overall, a systematic description of the biological foundation of PBS syndrome is lacking. Thus, the present study utilizes system biology methodologies and constructs a multi-omics network by integrating differential genes, proteins, and metabolites to systematically and comprehensively reveal the biological basis of CHD-PBS syndrome. The current study explored 1) the characteristics of the transcriptome, proteome, and metabolome for CHD-PBS syndrome; 2) the \u201cgene\u2013protein\u2013metabolite\u201d network based on differential genes (DGs), differential proteins (DPs), and differential metabolites (DMs); 3) the key biological process and metabolic pathway most related to PBS syndrome; and 4) quantitative results and the diagnostic potential of biomarkers for PSB syndrome. Materials and methods. Multi-omics sequencing, bioinformatics analysis, and clinical validation research strategy. We collected the blood samples from healthy subjects as well as CHD patients with PBS and non-phlegm and blood stasis (NPBS) syndrome to compare the differences between them by subjecting the samples to the transcriptome, proteome, and metabolomics analyses. Bioinformatics analysis identified differential molecules as well as related biological processes and pathways. Next, the \u201cgene\u2013protein\u2013metabolite\u201d network was constructed using the MetaboAnalyst database, String database, and Cytoscape software. We selected molecules with strong centrality and biological association as potential PBS syndrome biomarkers and recruited more volunteers for further validation by enzyme-linked immunosorbent assay (ELISA). Finally, the ROC curve was utilized to assess the level and diagnostic efficacy of various molecules (\n Figure 1)<\/jats:xref>\n .\n <\/jats:p>","DOI":"10.3389\/fphar.2022.1022627","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:14:36Z","timestamp":1669680876000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Exploring the \u201cgene\u2013protein\u2013metabolite\u201d network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy"],"prefix":"10.3389","volume":"13","author":[{"given":"Guang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinuo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.biopha.2018.08.004","article-title":"IL-1\u03b2 reduces cardiac lymphatic muscle contraction via COX-2 and PGE2 induction: Potential role in myocarditis","volume":"107","author":"Al-Kofahi","year":"2018","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1080\/15384101.2019.1662678","article-title":"Neutrophil extracellular traps induced by IL-8 aggravate atherosclerosis via activation NF-\u03baB signaling in macrophages","volume":"18","author":"An","year":"2019","journal-title":"Cell Cycle"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1056\/NEJMc2024008","article-title":"Invasive or conservative strategy for stable coronary disease. Reply","volume":"383","author":"Antman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/antiox8120620","article-title":"Anti-atherosclerotic effect of Hibiscus leaf polyphenols against tumor necrosis factor-alpha-induced abnormal vascular smooth muscle cell migration and proliferation","volume":"8","author":"Chou","year":"2019","journal-title":"Antioxidants"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1002\/jcp.24939","article-title":"Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction","volume":"230","author":"Dai","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"911861","DOI":"10.3389\/fmed.2022.911861","article-title":"Advances and trends in omics technology development","volume":"9","author":"Dai","year":"2022","journal-title":"Front. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/01.RES.0000163017.13772.3a","article-title":"CCL2\/Monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts","volume":"96","author":"Dewald","year":"2005","journal-title":"Circ. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e12840","DOI":"10.1111\/sji.12840","article-title":"IL-17 stimulates the expression of CCL2 in cardiac myocytes via Act1\/TRAF6\/p38MAPK-dependent AP-1 activation","volume":"91","author":"Du","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"664320","DOI":"10.3389\/fphar.2021.664320","article-title":"Serum metabolomic analysis of coronary heart disease patients with stable Angina pectoris subtyped by traditional Chinese medicine diagnostics reveals biomarkers relevant to personalized treatments","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","article-title":"Synopsis of arachidonic acid metabolism: A review","volume":"11","author":"Hanna","year":"2018","journal-title":"J. Adv. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.4049\/jimmunol.1601330","article-title":"The AP-1 transcription factor c-jun promotes arthritis by regulating cyclooxygenase-2 and arginase-1 expression in macrophages","volume":"198","author":"Hannemann","year":"2017","journal-title":"J. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"154923","DOI":"10.1016\/j.cyto.2019.154923","article-title":"Chemokine (C-C motif) ligand 2 and coronary artery disease: Tissue expression of functional and atypical receptors","volume":"126","author":"Hern\u00e1ndez-Aguilera","year":"2020","journal-title":"Cytokine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1093\/eurheartj\/ehx492","article-title":"Early diagnosis of acute coronary syndrome","volume":"38","author":"Katus","year":"2017","journal-title":"Eur. Heart J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.07.007","article-title":"Immunotherapy for the prevention of atherosclerotic cardiovascular disease: Promise and possibilities","volume":"276","author":"Khambhati","year":"2018","journal-title":"Atherosclerosis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.15829\/1560-4071-2020-2-3757","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes the Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"25","author":"Knuuti","year":"2019","journal-title":"Russ. J. Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1053\/j.semperi.2018.09.004","article-title":"Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia","volume":"42","author":"Lal","year":"2018","journal-title":"Semin. Perinatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.biopha.2018.10.087","article-title":"Low serum levels of CCL2 are associated with worse prognosis in patients with acute coronary syndrome: 2-year survival analysis","volume":"109","author":"Leoc\u00e1dio","year":"2019","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s13105-021-00812-1","article-title":"MiR-137 regulates low-intensity shear stress-induced human aortic endothelial cell apoptosis via JNK\/AP-1 signaling","volume":"77","author":"Li","year":"2021","journal-title":"J. Physiol. Biochem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1749-8546-7-9","article-title":"Inquiry diagnosis of coronary heart disease in Chinese medicine based on symptom-syndrome interactions","volume":"7","author":"Li","year":"2012","journal-title":"Chin. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8193","DOI":"10.3892\/mmr.2015.4432","article-title":"Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factor-\u03baB, monocyte chemoattractant protein-1, activator protein-1 and restoration of heat shock protein 72","volume":"12","author":"Lin","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"9940","DOI":"10.21037\/apm-21-2332","article-title":"Study on syndrome differentiation strategy of phlegm and blood stasis syndromes of coronary heart disease based on expert consultation on medical cases","volume":"10","author":"Liu","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1111\/j.1742-4658.2007.05772.x","article-title":"Caspase-8- and JNK-dependent AP-1 activation is required for Fas ligand-induced IL-8 production","volume":"274","author":"Matsumoto","year":"2007","journal-title":"FEBS J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1042\/CS20110234","article-title":"Activator protein-1 (AP-1) signalling in human atherosclerosis: Results of a systematic evaluation and intervention study","volume":"122","author":"Meijer","year":"2012","journal-title":"Clin. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"155213","DOI":"10.1016\/j.metabol.2022.155213","article-title":"Vascular smooth muscle cell c-Fos is critical for foam cell formation and atherosclerosis","volume":"132","author":"Miao","year":"2022","journal-title":"Metabolism."},{"key":"B25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/hrt.2008.154856","article-title":"Coronary heart disease epidemics: Not all the same","volume":"95","author":"Mirzaei","year":"2009","journal-title":"Heart"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e040533","DOI":"10.1002\/alz.040533","article-title":"Proteomic, metabolomic, and transcriptomic examination of APOE transgenic mice","volume":"16","author":"Mohler","year":"2020","journal-title":"Alzheimer's. &. Dement."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4049\/jimmunol.2100866","article-title":"Porphyromonas gingivalis gingipains induce cyclooxygenase-2 expression and prostaglandin E2 production via ERK1\/2-activated AP-1 (c-Jun\/c-Fos) and IKK\/NF-\u03baB p65 cascades","volume":"208","author":"Nakayama","year":"2022","journal-title":"J. I."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.amjcard.2009.06.028","article-title":"The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction","volume":"104","author":"Orn","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/med.21847","article-title":"Association predictions of genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, radiomics, drug, symptoms, environment factor, and disease networks: A comprehensive approach","volume":"42","author":"Pan","year":"2022","journal-title":"Med. Res. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1177\/1933719114549845","article-title":"Relationship of advanced glycation end products with cardiovascular disease in menopausal women","volume":"22","author":"Pertynska-Marczewska","year":"2015","journal-title":"Reprod. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.imbio.2010.06.003","article-title":"Pro- and anti-inflammatory control of M-CSF-mediated macrophage differentiation","volume":"216","author":"Popova","year":"2011","journal-title":"Immunobiology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1089\/acm.2020.0008","article-title":"A quantitative diagnostic method for phlegm and blood stasis syndrome in coronary heart disease using tongue, face, and pulse indexes: An exploratory pilot study","volume":"26","author":"Ren","year":"2020","journal-title":"J. Altern. Complement. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3892\/ijmm.4.3.223","article-title":"Oxidant stress regulation of IL-8 and ICAM-1 gene expression: Differential activation and binding of the transcription factors AP-1 and NF-kappaB (review)","volume":"4","author":"Roebuck","year":"1999","journal-title":"Int. J. Mol. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-3-642-77377-8_5","article-title":"The biology of CSF-1 and its receptor","volume":"181","author":"Roth","year":"1992","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40265-017-0691-7","article-title":"Drug therapy for stable Angina pectoris","volume":"77","author":"Rousan","year":"2017","journal-title":"Drugs"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1194\/jlr.M005215","article-title":"Arterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis","volume":"51","author":"Shaposhnik","year":"2010","journal-title":"J. Lipid Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.107.743963","article-title":"Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy","volume":"117","author":"Shaw","year":"2008","journal-title":"Circulation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fpls.2015.01143","article-title":"Heavy metal tolerance in plants: Role of transcriptomics, proteomics, metabolomics, and ionomics","volume":"6","author":"Singh","year":"2016","journal-title":"Front. Plant Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1096\/fj.01-0353fje","article-title":"Transcription activator protein 1 (AP-1) mediates NO-induced apoptosis of adult cardiomyocytes","volume":"15","author":"Taimor","year":"2001","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1080\/17512433.2016.1195263","article-title":"Herbal medicines: Challenges in the modern world. Part 3. China and Japan","volume":"9","author":"Teng","year":"2016","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B41","first-page":"539","article-title":"Diagnostic criteria for syndrome elements of coronary heart disease angina","volume":"59","author":"Wang","year":"2018","journal-title":"J. Tradit. Chin. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/2046-4053-2-51","article-title":"Bibliometric and content analysis of the Cochrane Complementary Medicine Field specialized register of controlled trials","volume":"2","author":"Wieland","year":"2013","journal-title":"Syst. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13020-021-00521-3","article-title":"Exploring biological basis of Syndrome differentiation in coronary heart disease patients with two distinct Syndromes by integrated multi-omics and network pharmacology strategy","volume":"16","author":"Wu","year":"2021","journal-title":"Chin. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/FJC.0000000000000769","article-title":"Berberine attenuates cholesterol accumulation in macrophage foam cells by suppressing AP-1 activity and activation of the Nrf2\/HO-1 pathway","volume":"75","author":"Yang","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1006\/jmcc.2001.1351","article-title":"Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats","volume":"33","author":"Yoshiyama","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12012-011-9135-x","article-title":"Toxicological insight from AP-1 silencing study on proliferation, migration, and dedifferentiation of rat vascular smooth muscle cell","volume":"12","author":"Zhang","year":"2012","journal-title":"Cardiovasc. Toxicol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.cmet.2021.08.014","article-title":"Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell Metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"871142","DOI":"10.3389\/fcvm.2022.871142","article-title":"A landscape of metabonomics for intermingled phlegm and blood stasis and its concurrent syndromes in stable Angina pectoris of coronary heart disease","volume":"9","author":"Zheng","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1021\/acs.jproteome.8b00799","article-title":"A large-scale, multi-center urine biomarkers identification of coronary heart disease in TCM syndrome differentiation","volume":"18","author":"Zhou","year":"2019","journal-title":"J. Proteome Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11684-014-0349-8","article-title":"Clinical phenotype network: The underlying mechanism for personalized diagnosis and treatment of traditional Chinese medicine","volume":"8","author":"Zhou","year":"2014","journal-title":"Front. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2021.05.009","article-title":"Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis","volume":"171","author":"Zhou","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-022-09856-4","article-title":"Purinergic signaling in myocardial ischemia-reperfusion injury","author":"Zhuang","year":"2022","journal-title":"Purinergic Signal."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1022627\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:14:40Z","timestamp":1669680880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1022627\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":52,"alternative-id":["10.3389\/fphar.2022.1022627"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1022627","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"article-number":"1022627"}}